Завершено
Фаза III
EPREX®; EPIAO® · Shenyang Sunshine Pharmaceutical Co., LTD.
A Prospective, Randomized, Double Blind, Parallel Group Study to Evaluate a 1:1 Dose Conversion From EPREX to EPIAO in Term of Clinical Efficacy and Safety in Subjects With End-Stage Renal Disease on Haemodialysis